Expediting the drug approval process: An analysis of the FDA Modernization Act of 1997

被引：0

作者：

Parver, DG ^{[1
]}

机构：

[1] American Univ, Washington Coll Law, Washington, DC 20016 USA

来源：

ADMINISTRATIVE LAW REVIEW | 1999年 / 51卷 / 04期

关键词：

D O I：

暂无

中图分类号：

D9 [法律]; DF [法律];

学科分类号：

0301 ;

摘要：

引用

页码：1249 / 1266

页数：18

共 50 条

[21] The FDA Modernization Act 2.0: Drug Testing in Animals is Rendered Optional
Adashi, Eli Y.
O'Mahony, Daniel P.
Cohen, I. Glenn
AMERICAN JOURNAL OF MEDICINE, 2023, 136 (09) : 853 - 854
[22] FDA and drug approval
Faich, GA
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 1995, 6 (06) : S24 - S24
[23] THE FDA APPROVAL PROCESS
HOKE, F
SCIENTIST, 1994, 8 (18) : 6 - 6
[24] The US Food and Drug Administration Modernization Act of 1997: Impact on consumers
Golodner, LF
CLINICAL THERAPEUTICS, 1998, 20 : C20 - C25
[25] Food and drug administration modernization act of 1997: Medical device provisions
Pilot, LR
Waldmann, DR
FOOD AND DRUG LAW JOURNAL, 1998, 53 (02): : 267 - 295
[26] The effects of the Prescription Drug User Fee Act and the Food and Drug Administration Modernization Act on the development and approval of therapeutic medicines
Reichert, JM
Chee, J
Kotzampaltiris, CS
DRUG INFORMATION JOURNAL, 2001, 35 (01): : 85 - 94
[27] The Effects of the Prescription Drug User Fee Act and the Food and Drug Administration Modernization Act on the Development and Approval of Therapeutic Medicines
Janice M. Reichert
Jennifer Chee
Claire S. Kotzampaltiris
Drug information journal : DIJ / Drug Information Association, 2001, 35 (1): : 85 - 94
[28] DRUG APPROVAL PROCESS - MIXED REVIEWS FOR FDA REFORM PLANS
EMBER, L
CHEMICAL & ENGINEERING NEWS, 1991, 69 (47) : 4 - 5
[29] FDA primer .1. The drug and biologic approval process
Mackler, BF
Landa, MM
Gamerman, GE
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 1996, 23 : 191 - 196
[30] FDA Primer: I. the drug and biologic approval process
Mackler, B. F.
Landa, M. M.
Gamerman, G. E.
Biotechnology and Applied Biochemistry, 1996, 23 (03):

← 1 2 3 4 5 →